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Summary
Helicobacter pylori can cause peptic ulcer disease
and/or gastric cancer. Adhesion of bacteria to the
stomach mucosa is an important contributor to the
vigour of infection and resulting virulence. H. pylori
adheres primarily via binding of BabA adhesins to
ABO/Lewis b (Leb) blood group antigens and the
binding of SabA adhesins to sialyl-Lewis x/a (sLex/a)
antigens. Similar to most Gram-negative bacteria, H.
pylori continuously buds off vesicles and vesicles
derived from pathogenic bacteria often include
virulence-associated factors. Here we biochemically
characterized highly puriﬁed H. pylori vesicles. Major
protein and phospholipid components associated
with the vesicles were identiﬁed with mass spectros-
copy and nuclear magnetic resonance. A subset of
virulence factors present was conﬁrmed by immuno-
blots. Additional functional and biochemical analysis
focused on the vesicle BabA and SabA adhesins and
their respective interactions to human gastric epithe-
lium. Vesicles exhibit heterogeneity in their protein
composition, which were speciﬁcally studied in res-
pect to the BabA adhesin. We also demonstrate that
the oncoprotein, CagA, is associated with the surface
of H. pylori vesicles. Thus, we have explored mecha-
nisms for intimate H. pylori vesicle–host interactions
and found that the vesicles carry effector-promoting
properties that are important to disease development.
Introduction
Helicobacter pylori is estimated to have infected more than
half of all people worldwide. Of the infected individ-
uals, ~10% develop peptic ulcer disease and 1–2%
develop gastric cancer (Cover et al., 2001). Furthermore,
individuals infected by H. pylori persist as non-
symptomatic carriers for their lifetime. Host inﬂammatory
responses and effector molecules produced by H. pylori-
infected cells cause changes in the gastric mucosa during
infection, requiring H. pylori to be able to adapt to an
ever-changingenvironment.Severalfactorswithvitalroles
in the colonization of H. pylori and the development of
disease have been described. These factors include the
urease enzyme, ﬂagella, the vacuolating cytotoxin VacA
and the cag-pathogenicity island (cagPAI), which encodes
the CagAprotein and a type IV secretion (T4S) machinery
that translocates CagA into host cells (Segal et al., 1999;
Odenbreit et al., 2000). Both phosphorylated and non-
phosphorylated CagA have been shown to interfere with
host signalling pathways and cellular functions (Higashi
et al., 2002; Hatakeyama, 2006; Suzuki et al., 2009).
Adherence is important for persistent infection of a host
and is mediated by the binding of bacteria to glycoproteins
and/orglycolipidspresentonthehostcellsurface.Analysis
of gastric biopsy material has shown that H. pylori popula-
tions are found deep in the mucous layer, and a subset is
attached to the surface of epithelial cells (Hessey et al.,
1990). Recent reports have also suggested H. pylori to be
localized intracellularly (Semino-Mora et al., 2003; Oh
et al., 2005; Aspholm et al., 2006a). Several receptor
structures for adherence of H. pylori to human gastric
epithelial cells have been described, suggesting that H.
pylori exhibits a multitude of adherence modes, which may
changeasinfectionprogresses(Gerhardet al.,2001).Two
functional receptors for H. pylori, fucosylatedABO/Lewis b
antigens (Leb) (Borén et al., 1993; Aspholm-Hurtig et al.,
2004) and sialyl-Lewis x/a antigens (sLex/a) (Mahdavi
et al., 2002), have been described in detail. In healthy
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© 2010 Blackwell Publishing Ltdhuman gastric epithelium, only minute levels of sialylated
glycans are detected, but upon infection by H. pylori,
increased expression of the inﬂammation/selectin-
associated sLex occurs (Mahdavi et al., 2002; Kobayashi
et al., 2004). Bacterial adherence to host cells is mediated
by adhesins on the bacterial cell surface. Correspondingly,
the H. pylori blood group antigen binding adhesin (BabA)
mediates binding to theABO/Leb receptor structures (Ilver
et al.,1998),andbindingtosLex/aismediatedbythesialic
acid binding adhesin (SabA) (Mahdavi et al., 2002;
Aspholm et al., 2006a).
Gram-negative bacteria continuously shed vesicles
from the cell surface during their growth. These vesicles
are 20–300 nm in size and are surrounded by an outer
membrane (OM) layer, which is described to have a com-
position derived from the bacteria’s OM. Upon shedding
from the bacterial cell surface, some of the underlying
periplasmic and cytoplasmic proteins, as well as DNAand
RNA, are contained within the vesicles (Beveridge, 1999;
Kuehn and Kesty, 2005; Mashburn-Warren and Whiteley,
2006). The biological role of these vesicles has not been
fully elucidated, but is described to be involved in toxin
delivery, protein and DNAtransfer, and signalling between
bacteria. Biochemical characterization of vesicles isolated
from pathogenic species has identiﬁed virulence-
associated factors such as toxins, invasins and host–
effector molecules (Horstman and Kuehn, 2000; Wai
et al., 2003; Kesty and Kuehn, 2004; Post et al., 2005;
Balsalobre et al., 2006; Tan et al., 2007; Vidakovics et al.,
2010). Electron micrographs of plasma from a person
infected with Neisseria meningitidis serogroup B that died
of septic shock showed that numerous vesicles were
present (Namork and Brandtzaeg, 2002). H. pylori
vesicles were found in gastric mucosal biopsy material
and shown to contain the VacA cytotoxin (Fiocca et al.,
1999; Keenan et al., 2000; Ricci et al., 2005). Recently,
peptidoglycan present in H. pylori vesicles was described
to upregulate NF-kB and Nod1-dependent responses
(Kaparakis et al., 2010). Although interactions between
host cells and bacterial vesicles have been described in
vitro (Beveridge, 1999; Kuehn and Kesty, 2005), details in
the adherence mechanisms are still poorly deﬁned.
Here we provide a detailed biochemical and functional
characterization of the vesicles that are released from H.
pylori. We established protocols for the isolation and puri-
ﬁcation of H. pylori vesicles according to size or density.
Major protein and phosholipid components present were
identiﬁed with nano-liquid chromatography Fourier
transform-ioncyclotronresonancemassspectrometryand
tandem mass spectrometry analysis (nanoﬂow LC FT-ICR
MS/MS) and high-resolution liquid state 31P, 1H nuclear
magnetic resonance (NMR) respectively. We demonstrate
that the protein content of H. pylori vesicles differs signiﬁ-
cantly from whole bacterial cells as well as of the OM.
Using immunoblots we conﬁrmed the presence of a
series of virulence factors in the vesicles such as adher-
ence components and the oncoprotein CagA. In particu-
lar, we focused on biochemical characterization and
functional analysis of adherence components present on
the surface of H. pylori vesicles. We used receptor con-
jugates for electron microscopy studies and an in vitro
assay to characterize adherence to human gastric tissue
sections. The results of these studies provide valuable
insight into the mechanisms involved in bacterial–host
interactions as they relate to H. pylori vesicles and their
intimate interaction with human gastric mucosa.
Results
Isolation of H. pylori vesicles
To biochemically analyse H. pylori vesicles, optimal
growth phase conditions for the isolation of vesicles
needed to be established. For this purpose, H. pylori
strain CCUG17875 was harvested at different time points
from Brucella blood agar and visualized by electron
microscopy to follow changes in morphology and vesicle
production (Fig. 1). H. pylori collected during the logarith-
mic growth phase were spiral-shaped and produced small
numbers of vesicles (Fig. 1A). Upon entry into stationary
phase, H. pylori became curved and later doughnut-
shaped while producing a greater number of vesicles
(Fig. 1B). During late stationary phase, H. pylori had
become coccoid and produced large amounts of vesicles
(Fig. 1C). For further experiments, H. pylori were har-
vested in the early stationary phase since cells were
viable, contained low levels of lysed cell debris, and pro-
duced sufficient quantities of vesicle material.
Helicobacter pylori vesicles were isolated and puriﬁed
from crude vesicle extracts by centrifugation to equilibrium
in a continuous density gradient (20–60%). Fractions
were collected from top to bottom and the gradient forma-
tion and protein concentration of each fraction was deter-
mined (Fig. 2A). Peaks in protein concentration were
identiﬁed in fractions 3–9 and fractions 15–24. Equal
volumes from each fraction were analysed for protein
24 h 48 h 72 h
1μm 1μm 1μm
ABC
Fig. 1. Vesicle production relative to bacterial growth. Electron
micrographs of the H. pylori strain, CCUG17875, harvested after
(A) 24 h; (B) 48 h; and (C) 72 h. Bar length represents 1 mm. Arrow
points out vesicles.
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and content varied between fractions. All fractions were
also analysed by electron microscopy to identify vesicle-
containing fractions (data not shown). Spherical vesicles
ranging in size from 20–300 nm dominated in fractions
3–9, and electron micrographs conﬁrmed that these frac-
tions contained puriﬁed vesicles free from bacterial debris
and soluble proteins compared to crude vesicle prepara-
tions (Fig. 2B and C).
With shorter centrifugation times, vesicles could be
separated according to size. A crude vesicle extract was
subjected to centrifugation on a continuous 5–15%
gradient. Size-separated fractions were then analysed by
SDS-PAGE (Fig. S1) and electron microscopy to conﬁrm
the separation of vesicles according to size (Fig. 3A–C).
The average vesicle size in each fraction was determined.
Fraction 2 contained vesicles of 50 nm, fraction 4 vesicles
of 94 nm, and fraction 9 vesicles of 108 nm (Fig. 3D).
Characterization of major phospholipid vesicle
components
Phospholipids present in H. pylori vesicles were identiﬁed
using two-dimensional (2D) 31P, 1H NMR correlation
spectra. The type and abundance of phospholipid compo-
nents present in isolated vesicles, outer and inner mem-
brane (IM) fractions, and whole H. pylori cells was
determined. By deﬁnition, IMs have fewer proteins than
OMs, thereby allowing IMs to be separated from OMs
using density gradient centrifugation. To localize fractions
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Fig. 2. Isolation of H. pylori vesicles according to density. Crude H. pylori vesicle preparations were subjected to ﬂotation and separated
using density gradients.
A. The density and protein concentration of each fraction was measured. The densities are depicted in grey and protein concentrations in
black.
B. The same volume from each fraction was analysed by SDS-PAGE. Fraction 1 corresponds to the top fraction and has the lowest density
(1.135 g ml
-1).
C. Electron micrographs of H. pylori vesicles from strain CCUG17875, are shown including: crude fraction, fraction 3, 5 and 7. Bar length
represents 0.5 mm.
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with SDS-PAGE and probed with markers for IM and OM
respectively (Fig. 4A and B). Antiserum against ComB10
was used as IM protein marker (Kutter et al., 2008) and a
strong signal was obtained in fraction 2. Weak or no
signals were obtained in fraction 1, 3, 4 and 5. BabA,
SabA and OipA are all OM proteins (Ilver et al., 1998;
Yamaoka et al., 2000; Mahdavi et al., 2002) and signals
Fig. 3. Analysis of H. pylori vesicles isolated
according to size. Crude H. pylori vesicle
preparations were separated on a gradient
according to size.
A–C. Electron micrographs of fractions 2, 4
and 9 that represent the differences in vesicle
size achieved by separation. Leb-binding
adhesins on the surface of the vesicles are
visualized with immunogold labelling of
Leb–receptor conjugates. Bar length
represents 0.2 mm.
D. A bar graph representing the average size
of vesicles isolated in fractions 2: 50 nm
(n = 207); 4: 94 nm (n = 146); and 9: 108 nm
(n = 188). Maximum and minimum ranges for
each fraction are represented by the two ends
of the vertical lines associated with each bar.
E. A bar graph representing the percentage of
Leb-binding vesicles present in each fraction,
i.e. fraction 2: 23% (n = 524); 4: 60%
(n = 351); and 9: 81% (n = 183). The
presented data represent one of three
independent sets of experiments.
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Fig. 4. Identiﬁcation of major phospholipid components in H. pylori vesicles. H. pylori membranes were fractionated using sucrose density
gradient centrifugation without detergents.
A. Equal volumes from the top ﬁve fractions were analysed by SDS-PAGE.
B. Fractions were probed in immunoblots for the IM protein ComB10, and the OM proteins BabA, SabA and OipA respectively.
C. Major phospholipids present in whole H. pylori bacterial cells (WC) versus inner membrane (IM, fraction 2), outer membrane (OM, fraction
3) and H. pylori vesicles (ves) were identiﬁed using high-resolution NMR. The displayed
31P projections of two-dimensional
31P,
1H correlation
spectra are scaled for equal intensity of the PE signals. Slight shifts in
31P positions are due to variations in solvent composition. The following
phospholipids were identiﬁed: Phosphatidylglycerol (PG), phosphatidyl ethanolamine (PE), lyso PE (LPE), phosphatidylcholine (PC), lyso PC
(LPC) and cardiolipin (CL).
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Fraction 2 was thereby deﬁned as the fraction where IM
dominated and fraction 3 deﬁned as the fraction where
OM dominated.
Lipids were extracted from whole bacteria, OM (Fig. 4A
and B, fraction 3), IM (Fig. 4A and B, fraction 2) and
puriﬁed vesicles. For analysis of the 2D spectra (Fig. S2),
1D projections were integrated (Fig. 4C). Phosphatidyle-
thanolamine (PE) and cardiolipin (CL) were identiﬁed as
the major phospholipids present in all fractions. IM frac-
tions contained considerably lower amounts of phosphati-
dylglycerol (PG) and lyso-phophatidyletanolamine (LPE)
compared with the OM or vesicle fractions. Phophatidyl-
choline (PC) was below the detection limit in IM, but was
readily detected in all other fractions (Fig. S2). These data
represent the differences in phospholipid composition
between the analysed fractions, and suggests that the
phospholipid composition of vesicles most closely
resembles that of the OM.
Helicobacter pylori membranes have been reported to
contain cholesterol (Inamoto et al., 1993), therefore we
used 13C,1H NMR correlation spectra to quantify the levels
of cholesterol present in whole cell and vesicle samples.
Relating the phospholipid signals with cholesterol signals
resulted in a molar fraction of cholesterol estimated to be
10% relative to that of total phospholipids present in both
whole bacterial cells as well as in vesicles (data not
shown).
Characterization of major proteins present in vesicles
The major protein components of H. pylori vesicles were
analysed using mass spectrometry (MS). Since many of
the H. pylori OM proteins are of similar molecular masses,
exhibit high pI values and do not resolve on 2D gels, 1D
SDS-PAGE was combined with analysis by the sensitive
nanoﬂow LC FT-ICR MS/MS method. Using H. pylori
vesicles puriﬁed according to density, samples with a
density of 1.15–1.20 g ml-1 from fractions 3–9 were
pooled. Initial separation of the samples by SDS-PAGE
identiﬁed a series of 34 bands that were excised and
subjected to peptide tandem mass determination
(Fig. 5A). All mass data obtained were searched by
MASCOT against all species in the NCBI database. An H.
pylori proteome consists of approximately 1500 putative
proteins (Alm et al., 1999; Oh et al., 2006; Baltrus et al.,
2009), and in total 306 different H. pylori proteins were
identiﬁed in the 34 excised bands (Table S1). Identiﬁed
vesicle proteins were classiﬁed according to Clusters of
Orthologous Groups (COG) for the total H. pylori pro-
teome (Table S1, Fig. 5B). Several H. pylori OM proteins
have been associated with gastric disease (Yamaoka and
Alm, 2008), and therefore H. pylori OM proteins are listed
as a separate group as classiﬁed according to Alm et al.
(2000).Amajority of all OM proteins (77%) were identiﬁed
in the vesicles (Fig. 5B). We used a sensitive MS method,
which may explain why we also found way more cytoplas-
mic and periplasmic components than previously shown
for bacterial vesicles. Several of the identiﬁed vesicle
proteins are associated with important roles in H. pylori
colonization and virulence, such as urease subunits, the
cytotoxin VacA, CagA, and the BabA and SabA adhesins.
We also found g-glutamyl transpeptidase that similar to
the VacA protein has been shown to exhibit immunosup-
pressive effects (Schmees et al., 2007) and the protease
HtrA(Löwer et al., 2008).Among the series of cytoplasmic
proteins we found GroEL, catalase, metabolic and riboso-
mal proteins.
A second MS analysis (MS II) was performed on an
additional vesicle sample of a narrower density interval
(1.17–1.18 g ml-1). Separation by SDS-PAGE resolved a
series of 32 bands that were isolated (Fig. S3) and sub-
jected to nanoﬂow LC FT-ICR MS/MS analysis. From this
sample, 126 different H. pylori proteins were identiﬁed.
Among these, 93% were identical to the previous analysis
(Fig. 5C, Table S1) and 7% were speciﬁc for MS II
(Table S2).
The content of bacterial vesicles have been described
to resemble the OM (Beveridge, 1999; Kuehn and Kesty,
2005; Mashburn-Warren and Whiteley, 2006). Since the
MS analysis is not quantitative, we wanted to determine
the relative amount in a series of virulence-associated
proteins in the OM and vesicles. The same amount of
protein was analysed in immunoblots for the BabA, SabA
and AlpB proteins, in addition to the CagA and the HtrA
proteins (Fig. 5D). The expression level of the respective
proteins in vesicles was related to the levels in OM
(Fig. 5D). The BabA and the SabA adhesins were mark-
edly enriched in the OM relative to the levels in the
vesicles. The same enrichment in the OM was not as
obvious for the AlpB and the CagA proteins. Interestingly,
the relative HtrAlevel was higher in the vesicles (Fig. 5D).
In contrast to strain CCUG17875, strain P12 has a
functional T4S machinery. We probed for a series of T4S
associated proteins (CagT, CagX, CagY, CagN, CagM and
VirD4) and their presence in vesicles isolated from strains
P12 and CCUG17875 (Fig. S4). CagT, CagX, CagN and
CagMwereallpresentinvesiclesfromstrainCCUG17875.
Wealsonotedahigheramountoftheseproteinsinvesicles
from CCUG17875 than P12 vesicles. VirD4 was present in
P12 bacterial cells but no protein was detected in P12
vesicles. Additionally, we probed for the OipA protein and
showed its presence in both whole cells and vesicles from
strain CCUG17875 and P12 (Fig. S4).
Taken together, the results from the MS analysis and
the immunoblots support the view that vesicles are com-
prised of a protein composition that is distinct from whole
cells and OM respectively.
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Fig. 5. Identiﬁcation of major protein components in H. pylori vesicles.
A. Protein extracts of H. pylori CCUG17875 vesicles (fractions 3–9) were separated by both 10% and 15% SDS-PAGE to resolve the protein
bands present. Thirty-four of the most predominant bands (labelled to the right of each gel lane) were excised and subjected to nanoﬂow LC
FT-ICR MS/MS. Molecular weights (kDa) are marked to the left of each gel lane.
B. The identiﬁed vesicle proteins were sorted into functional COG classes and outer membrane proteins respectively. Dark grey bar
represents vesicle proteins in each class and light grey bars represent number of proteins of each class of the total H. pylori proteome. Out of
the total H. pylori proteome, 77% of all OM proteins were found in the vesicles; 21% of cellular processes; 21% of metabolism; 14% of
information, storage and processing; and 12% of poorly classiﬁed/not classiﬁed.
C. Comparison of MS I and MS II analyses presented as a Venn diagram. The two data sets are represented proportional to the size of the
data sets. Approximately 38% of the proteins identiﬁed in the MS I analysis were found in the MS II analysis, whereas 93% of proteins from
the MS II analysis were found in the MS I analysis.
D. OM proteins and vesicles were analysed by immunoblot using antibodies speciﬁc for the lipoprotein AlpB, the BabA adhesin, the SabA
adhesin, the CagA and the HtrA proteins respectively. Signal densities were measured. Signals corresponding to OM were set to 1.0 to
correlate the relative expression of signals obtained in vesicles. The ratio of OM versus vesicles were: AlpB: 1:0.7; BabA: 1:0.3; SabA: 1:0.3;
CagA: 1:0.9; HtrA: 1:2.0. The immunoblots shown in the ﬁgure represent one for each protein of a series of blots.
E. H. pylori CCUG17875 were grown on Brucella blood agar and in Brucella broth. Protein extracts of OM and of vesicles obtained from the
two different growth conditions were analysed for their protein expression patterns by SDS-PAGE. Molecular weights (kDa) are labelled on the
far left.
F. The same volume from fractions 1–11 of vesicles separated by density were analysed by immunoblotting using antibodies speciﬁc for BabA
adhesin, SabA adhesin, lipoprotein AlpB, CagA and VacA respectively.
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H. pylori vesicles and OM were isolated after growth
in Brucella broth cultures and blood agar. The samples
were analysed by SDS-PAGE (Fig. 5E) and clearly
demonstrate that differences in environmental con-
ditions affect the content of vesicles since the protein
pattern of broth and agar differed. In general, the vesicle
protein proﬁle resembled that of the OM, but some clear
distinctions in the protein pattern were also observed
(Fig. 5E).
Identiﬁcation of virulence-associated proteins
To identify potential virulence-associated factors present
in isolated fractions, immunoblot analysis was performed.
Protein extracts from H. pylori vesicles separated accord-
ing to density (i.e. fractions 1–11) were analysed by immu-
noblot with antibodies speciﬁc for the BabA and SabA
adhesins, VacA, AlpB and CagA (Fig. 5F). Immunoblot
analysis with antibodies speciﬁc for the OM protein OipA
showed that fractions 5–7 were associated with the OipA
protein (data not shown). The results of the immunoblots
also verify that vesicles are heterogeneous in their protein
content.
Speciﬁc adhesion–receptor interactions of H. pylori
vesicles
To analyse if the BabA and the SabA adhesins are
present on the vesicle surface and also their ability to
bind their cognate receptors, a combination of streptavi-
din conjugated gold particles and receptor conjugates
were used for visualization of binding by electron
microscopy. For these studies, three H. pylori strains
were included: strain CCUG17875, which expresses
both BabA and SabA adhesins, a variant clone, 17875/
Leb, which only has Leb-binding properties, and strain
17875/sLex, which expresses the SabA adhesin but
has the babA1 and babA2 genes knocked-out. Vesicles
from strains 17875/Leb (BabA+/SabA-) and 17875/sLex
(BabA-/SabA+) were probed with biotinylated Leb/sLex
receptor conjugates and bound conjugate was detected
with streptavidin conjugated gold particles (Fig. 6). Gold
particles were distributed over the surface of BabA+
vesicles isolated from 17875/Leb when incubated
with the Leb–receptor conjugate (Fig. 6A). In contrast,
only a few gold particles were detected on vesicles iso-
lated from the Leb-non-binding mutant strain, 17875/
sLex (Fig. 6B). When vesicles isolated from strain
17875/sLex (SabA+) were probed with the sLex conju-
gate, gold particles were detected on the surface of
SabA+ vesicles (Fig. 6C). Vesicles isolated from strain
CCUG17875 (BabA+/SabA+) were subjected to double-
staining using BabA antibodies and the sLex–receptor
conjugate in combination with gold particles of 10 and
5 nm in size respectively. Thus, one and the same
vesicle can exhibit both Leb and sLex-binding properties
(Figs 6E and S5).
Helicobacter pylori vesicles separated according to
their size were also analysed for the presence of Leb-
binding adhesins. In general, it appeared that larger
vesicles typically carried more Leb-binding BabA adhes-
ins than smaller H. pylori vesicles (Fig. 3A–C). Back-
ground staining was more commonly observed in
samples containing smaller vesicles, which we hypoth-
esize to be staining that corresponds with the presence
of soluble proteins identiﬁed in fractions 1 and 2
(Fig. S1). Gold particles corresponding to Leb-binding of
BabA adhesins visible on electron micrographs from
fractions 2, 4 and 9 were counted. The proportion of
Leb-binding vesicles present in each fraction correlated
with the number of larger vesicles present in each frac-
tion. For example, fraction 2 contained 23% of Leb-
binding vesicles, fraction 4 contained 60% of Leb-
binding vesicles, and fraction 9 contained 81% of Leb-
binding vesicles (Fig. 3E).
Further biochemical characterization of the vesicle
BabA–Leb-binding properties was performed using a
modiﬁed Scatchard method (Aspholm et al., 2006b)
(described in Experimental procedures) to measure the
affinity. The affinities of whole 17875/Leb bacterial cells
versus vesicles isolated from the same strain were similar
(Fig. 6F). Whole bacterial cells of strain 17875/Leb exhib-
ited an affinity for Leb of Ka = 1.34E + 11, while the affinity
of vesicles for Leb was Ka = 1.42E + 11. The observation
that the BabA adhesin of H. pylori vesicles binds to the
Leb–receptor with the same affinity as whole bacterial
cells suggests that the adhesins presented by H. pylori
vesicles exhibit a similar folding as the adhesins pre-
sented on whole bacterial cells.
Properties for intimate adherence of H. pylori vesicles to
human gastric mucosa
Helicobacter pylori vesicles have previously been identi-
ﬁed to attach to and to be taken up by human epithelial
cells (Fiocca et al., 1999; Heczko et al., 2000); however,
details in the adherence properties of H. pylori vesicles
have remained elusive. Vesicles from strain 17875/Leb
(BabA+/SabA-) and 17875/sLex (BabA-/SabA+) were
analysed for binding in vitro to human gastric mucosa.
Histo-tissue sections were probed with vesicles and
bound vesicles were identiﬁed with antibodies against H.
pylori. Both BabA (Figs 7A and S6) and SabA (Figs 7C
and S6) mediated binding of vesicles to the gastric epi-
thelial lining. To study the adhesion–receptor speciﬁcity
operating in the vesicle–tissue interaction in more detail,
vesicles were pre-incubated with receptor conjugate prior
H. pylori vesicles and properties for adhesion 1545
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 1539–1555to incubation with the gastric tissue sections. Pre-
incubation of 17875/Leb vesicles with Leb–receptor
conjugate blocked BabA–Leb mediated adherence dem-
onstrating the role of the BabA adhesins in mediating H.
pylori binding (Figs 7B and S6). In contrast, pre-
incubation of 17875/Leb vesicles with sLex–receptor con-
jugate did not affect adherence (data not shown).
However, pre-incubation of 17875/sLex vesicles with sLex
receptor conjugate did abolish adherence to the gastric
mucosa (Figs 7D and S6), while pre-incubation with Leb
did not affect adherence (data not shown). Thus, H. pylori
vesicles carries biologically active, fully folded BabA and
SabAadhesins on the surface, which can mediate speciﬁc
interactions to receptors present in human gastric
mucosa.
CagA is associated with the surface of H. pylori vesicles
Biochemical analysis identiﬁed CagA as a protein compo-
nent of H. pylori vesicles. Immunogold analysis localized
CagA to the bacterial cell surface, vesicle surface
(Fig. 8C), and surroundings of strain P12 (Fig. 8A). In
contrast, strain P12DcagA was negative for CagAstaining
as expected (Fig. 8B). The association of CagA with the
vesicle surface was further conﬁrmed using a protease
assay. H. pylori P12 vesicles were digested with trypsin in
the presence or absence of the detergent, NP40, and then
analysed by immunoblotting for the presence of CagA,
BabA and VacA proteins (Fig. 8D). Protease treatment
degraded CagA completely, while BabA was only partially
degraded. Based on these results, we hypothesize that
Fig. 6. Presence of receptor-binding
adhesins on the surface of H. pylori vesicles.
A. Electron microscopy was used to detect
the binding of biotinylated Leb–receptor
conjugates and streptavidin-conjugated gold
particles to BabA adhesins on the surface of
H. pylori vesicles isolated from strain
17875/Leb.
B. Only background labelling was observed
on vesicles isolated from strain 17875/sLex
that is devoid of BabA expression. Bar length
in A and B represents 0.5 mm.
C. sLex-binding adhesins were identiﬁed on
17875/sLex-derived vesicles using
sLex–receptor conjugate and
streptavidin-conjugated gold particles.
D. Only background labelling was observed
on vesicles isolated from strain 17875/Leb,
which lacks sLex-binding activity. Bar length
in C and D represents 0.2 mm.
E. Electron micrographs of vesicles incubated
with anti-BabA antibodies detected by 10 nm
gold particles and sLex receptor conjugate
detected by 5 nm gold particles. The larger
10 nm dots correspond to BabA adhesins and
the 5 nm dots represent SabA adhesins.
F. A receptor displacement assay according to
the Scatchard method was used to measure
the affinity constant (Ka)o f
125I-Leb receptor
conjugate to the BabA adhesin in H. pylori
whole cells (WC) (Ka = 1.34E + 11) versus
vesicles (ves) (Ka = 1.42E + 11) from strain
17875/Leb.
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in contrast to BabA that is an OM protein and partly
integrated into the vesicle membrane. VacA was com-
pletely degraded by protease treatment in the absence of
detergent, although in the presence of detergent VacA
was only partially degraded.
Discussion
Although the shedding of vesicles by Gram-negative bac-
teria was described several decades ago, the more recent
ﬁnding that vesicles shed from pathogenic bacteria can
act as vehicles for delivery of host–effector molecules and
toxins is of particular interest. Therefore, the vesicles of
disease-associated bacteria have signiﬁcant implications
for the pathogenesis of bacterial disease. Several studies
have focused on the delivery of toxins, particularly E. coli
toxins such as LT toxin, ClyA, CNF1 toxin and
a-haemolysin (Horstman and Kuehn, 2000; Wai et al.,
2003; Balsalobre et al., 2006; Kouokam et al., 2006). In
spite of detailed biochemical and functional analyses of
vesicles from a multitude of different species, the role of
bacterial vesicles in disease-associated pathogenesis is
still far from being clear. Here we studied vesicles of the
gastric pathogen, H. pylori, using detailed biochemical
assays. Major protein and phospholipid components were
Fig. 7. Adherence of H. pylori vesicles to
human gastric epithelium. Vesicle adherence
to the epithelium of human gastric mucosa via
BabA–Leb interactions and SabA–sLex
interactions was detected using biotinylated
anti-H. pylori antibody and
streptavidin-conjugated Cy3. Vesicles isolated
from H. pylori strains 17875/Leb
(BabA+/SabA-) and 17875/sLex
(BabA-/SabA+) were incubated with human
gastric tissue sections as follows:
A. 17875/Leb vesicles.
B. 17875/Leb vesicles pre-incubated with Leb
receptor conjugate prior to incubation with
gastric tissue sections.
C. 17875/sLex vesicles.
D. 17875/sLex vesicles pre-incubated with
sLex receptor conjugate prior to incubation
with gastric tissue sections. Bar lengths
represents 100 mm.
D
BabA+
100 μm
BabA+
+Leb
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B
SabA+
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A
Fig. 8. CagA is localized to the surface of H.
pylori vesicles. Immunogold-labelling of CagA
protein.
A. Electron micrographs of H. pylori strain
P12.
B. Electron micrographs of H. pylori strain
P12DcagA. Bar length in A and B represents
0.5 mm.
C. An enlargement of the indicated area in
(A).
D. Vesicles of strain P12 treated with Trypsin
(+), NP40 (++) or neither (-) as indicated.
Samples were analysed by immunoblot using
antibodies against BabA, CagA and VacA
respectively.
B
0.5 μm
CagA- CagA+
A
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characterized in more detail and in particular adherence
proteins and their role in speciﬁc mechanisms of vesicle–
host interactions.
The detailed mechanisms of vesicle formation are not
fully deﬁned. However, one approach to further under-
standing of the shedding mechanism and its potential
biological impact is to identify the composition of vesicles.
Samples of crude and gradient-puriﬁed vesicle fractions
were analysed by a combination of electron microscopy
and SDS-PAGE. These analyses demonstrated that
density centrifugation was sufficient to remove cell debris,
broken ﬂagella and soluble proteins that contaminated
crude vesicle fractions. To identify major vesicle protein
components, nanoﬂow LC FT-ICR MS/MS was used.
Bacterial vesicles have been described to contain pre-
dominantly OM proteins and periplasmic components;
however, LPS, cytoplasmic components, DNA and RNA
have also been found to be present (Horstman and
Kuehn, 2000; Wai et al., 2003; Post et al., 2005; Nevot
et al., 2006). We speciﬁcally identiﬁed peptides corre-
sponding to more than 300 different H. pylori proteins
from the 34 bands that were cut out from our vesicle
sample. A majority (77%) of all H. pylori OM proteins were
found in the vesicles. Despite the ability of MS to identify
peptides present in small amounts, the method is not
quantitative. Therefore, as seen upon comparison of
protein proﬁle of OM fractions and vesicles on SDS-
PAGE, the OM proteins present in the vesicles are in
greater abundance than other proteins, as described for
vesicles previously. Quantiﬁcation of a series of proteins
present in the OM and the vesicles show a clear distinc-
tion in the relative levels, which further shows that protein
composition of vesicles is clearly distinct from the OM as
well as intact H. pylori cells. The OM proteins represent
only 16% of the total number of proteins that we identiﬁed
in the vesicles. In addition, and in accordance with our
results and that of other laboratories recently summarized
by Lee et al. (2008), it is evident that cytoplasmic proteins
are naturally occurring components in bacterial vesicles
and possibly more abundant than previously appreciated.
The presence of cytoplasmic components can in part be
explained by the choice of experimental assays. Sensitive
MS methods, such as LC FT-ICR MS/MS, can detect
even small amounts of complex protein compositions in a
gel sample and thereby provide a more comprehensive
analysis. In addition, we probed vesicles with the IM
marker ComB10 in immunoblots and indeed obtained a
signal (data not shown). Thus, the suggested mecha-
nisms for shedding of vesicles may not be complete since
they do not include how IM and cytoplasmic proteins are
trapped within the vesicle lumen (Kuehn and Kesty, 2005;
Mashburn-Warren and Whiteley, 2006; Deatherage et al.,
2009).
The results of a proteome analysis are dependent on
the type of sample analysed. Environmental conditions
such as growth phase and growth medium affect gene
expression, which then will affect the composition of
vesicles produced. This is illustrated by the results of the
protein proﬁles of broth-derived vesicles versus agar-
derived vesicles that differed signiﬁcantly. In an MS
analysis of E. coli vesicles, vesicles of 20–40 nm were
predominant (Lee et al., 2007). An alternative selection of
vesicle samples would probably have given a somewhat
different outcome of the proteomic analysis. Therefore, it
is important that the results of an MS analysis are asso-
ciated with the speciﬁc conditions of the samples analy-
sed and not extrapolated to be a generalized conclusion.
The MS analysis in this study was based on the 34 most
prominent bands from an H. pylori sample corresponding
to growth on blood agar plates in vitro, although a more
ideal sample would have been vesicles derived from
biopsy material that would represent the in vivo expres-
sion pattern of proteins in H. pylori vesicles. Such protein
proﬁle would provide key factors to unravel the complex
biogenesis of vesicles.
To reliably deﬁne the phospholipid composition of H.
pylori membranes, we used liquid-state 31P, 1H NMR. The
composition of whole H. pylori cells, OM, IM and vesicles
was all dominated by PE and CL. These results are con-
sistent with studies of coccoid H. pylori cells (Shimomura
et al., 2004). The main phospholipids present in vesicles
differ between bacterial species. In vesicles of N. menin-
gitidis, PE and PG were most abundant (Post et al.,
2005). In these studies and previous studies of coccoid H.
pylori (Shimomura et al., 2004), signiﬁcant amounts of
LPE were detected in all membrane fractions, although
a smaller amount was detected in IM fractions. Both
lysophospholipids and CL have been associated with
increased membrane curvature (Huang et al., 2006).
Thus, the presence of lysophospholipids and CL in bac-
terial vesicles is hypothesized to be essential to achieve
the high degree of curvature associated with these
smaller vesicles. Alternatively, formation of lysophospho-
lipids might also be a sign of bacteria being under stress
and may play a role in destabilizing H. pylori membranes
(Tannaes et al., 2000; 2001). In studies by Tannaes and
co-workers a relationship between higher levels of lyso-
phospholipid present and ulcer disease was identiﬁed
(Tannaes et al., 2005). Future studies of lysophospholipid
content in vesicles from strains of bacteria associated with
various levels of peptic ulcer disease may provide addi-
tional insight into the possible role of lysophospholipids in
destabilizing membranes to facilitate uptake by the host to
affect disease outcome.
Adherence is an important step in the delivery of toxins
and other effector molecules by bacteria to target tissues.
So far, only few detailed mechanisms of the interactions
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described. To our knowledge, this study is the ﬁrst to
describe the biological activity and biochemical character-
ization of adhesins present on bacterial vesicles. MS
analysis identiﬁed both the BabA and SabA adhesins as
components of H. pylori vesicles, which was further con-
ﬁrmed in immunoblotting studies. Using receptor conju-
gates and electron microscopy, we could demonstrate
receptor-binding activity of both the BabA and the SabA
adhesin. The binding speciﬁcity of both adhesins was as
high as for whole bacterial cells (Ilver et al., 1998;
Mahdavi et al., 2002), and binding to gastric histo-tissue
sections was completely inhibited by pre-incubation with
cognate receptor conjugate prior to addition to the
sections. Biochemical analysis of BabA–Leb interactions
revealed that the Leb-binding affinity for vesicles was
almost identical to that of whole bacterial cells. This sug-
gests that BabA is functionally equivalent in vesicles and
whole bacterial cells, and that BabA proteins are dis-
played similar on both vesicles and whole bacterial cells.
Differences in size and density (i.e. protein/lipid ratio)
observed for vesicles reﬂect differences in vesicle
composition. When vesicle samples that differed in
density were compared in two separate MS analyses, the
MS II analysis of 32 bands from vesicles with a density of
1.17–1.18 g ml-1 identiﬁed 126 proteins, 93% of which
overlapped with proteins identiﬁed in the MS I analysis of
vesicles with densities of 1.15–1.20 g ml-1. The higher
density vesicles, probably containing a higher protein/lipid
ratio, therefore correlated with a greater number of pro-
teins identiﬁed. Differences in protein content between
vesicles and the impact of these differences in biological
activity as here illustrated in terms of receptor binding
were clearly illustrated by the higher prevalence of Leb-
binding BabA adhesins identiﬁed in the larger vesicles.
Balsalobre and co-workers have also found differences in
the composition in E. coli vesicles, with a-haemolysin
associated with larger vesicles (Balsalobre et al., 2006).
However, not all H. pylori vesicles analysed carried Leb-
binding or sLex-binding adhesins. Similar observations of
differences in vesicle phenotypes were reported by Kesty
and Kuehn (2004). In these studies, only vesicles carrying
the OM Ail adhesin/invasin were taken up by host cells
and not vesicles devoid of the Ail protein. In addition, LPS
has been described to affect shedding of bacterial
vesicles and possibly also the size of the shedded
vesicles (Kadurugamuwa and Beveridge, 1998; Nguyen
et al., 2003; Mashburn-Warren and Whiteley, 2006).
Although the role of bacterial vesicles in pathogenesis
is not fully understood, some characteristics have been
established. For example, delivery of host–effector mol-
ecules and toxins has been demonstrated, and a preda-
tory role for these factors has been identiﬁed based on
the presence of anti-bacterial factors such as auto-lysin
detected in vesicles of Pseudomonas aeruginosa. Auto-
lysin has been shown to effect the degradation of cell
walls of both Gram-positive and Gram-negative bacteria
(Li et al., 1996). Moreover, Tan and co-workers have dem-
onstrated that Moraxella catarrhalis vesicles carrying the
UspA1/A2 proteins contribute to serum resistance and
increased survival of co-infecting Haemophilus inﬂuenzae
(Tan et al., 2007). Vesicles of M. catarrhalis have also
been shown to act as decoys in B-cell interaction and
redirect the adaptive humoral immune response by avoid-
ing direct contact with the bacteria (Vidakovics et al.,
2010). Similarly, Neisseria gonorrhoeae has also been
shown to protect itself from bactericidal factors via
vesicles elaborated from serum-resistant strains. Such
vesicles were found to have an inhibitory effect on the
destruction caused by normal human serum (Pettit and
Judd, 1992).
In addition to the BabA and SabA adhesins, we also
identiﬁed other virulence-associated factors including the
urease subunits, OipA and the CagA protein. We con-
ﬁrmed that the VacAtoxin can be associated with H. pylori
vesicles, consistent with the results of other studies
(Fiocca et al., 1999; Ricci et al., 2005). The effector and
oncoprotein, CagA, has been described to induce
changes in cell morphology, cell motility, differentiation
and polarity (Hatakeyama, 2008). Using immunogold
electron microscopy, we demonstrated that CagA is
present on the surface of vesicles. Further analysis using
a protease assay suggested that CagA is associated to
the surface of vesicles. This is in contrast with the pro-
tease assay results for the BabA adhesin where trypsin
digestion was incomplete even in the presence of deter-
gents, supporting that BabA is an integral component of
the OM. In the presence of detergent trypsin could only
partially degrade VacA. Delivery of VacA by vesicles
induces a vacuolating phenotype, although with lower
vacuolating activity then that mediated by whole bacteria
(Ricci et al., 2005), which suggest differences in
oligomerization. One interpretation of our result is that the
detergent induces oligomerization of VacA and thereby
the trypsin cleavage sites are hidden.
Injection of CagA by bacteria is dependent on the T4S
component, CagL, and its interaction with b1-integrins
(Kwok et al., 2007). In our studies we identiﬁed several
proteins encoded by the cagPAI. With histo-sections from
human gastric epithelium, we showed here that both the
BabAand SabAadhesins on the vesicle surface mediated
speciﬁc receptor interactions with human gastric tissue.
Clearly, an exciting possibility is that delivery of CagA to
gastric host cells might be mediated by H. pylori vesicles
and thus may occur independently of CagL or a complete
T4S system. Uptake of vesicles by membrane fusion has
been described for P. aeruginosa and uptake via endocy-
tosis of E. coli vesicles (Kesty et al., 2004; Bomberger
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Further analysis of pathways for uptake of H. pylori
vesicles and delivery of host–effector proteins, such as
CagA, are currently explored in our laboratory.
The small genome of H. pylori requires the bacterium to
be dependent on nutrient leakage from host cells. Adher-
ence facilitates access of H. pylori to nutrients, while at
the same time promotes delivery of bacterial toxins and
host–effector molecules. In such perspective, adherence
may be devastating due to the vigour of bactericidal
host responses. The persistent, often lifelong infections
caused by H. pylori probably result from a balanced rela-
tionship between the needs of H. pylori and the defences
of the host. It is therefore possible that direct contact of
vesicles with host cells may allow the bacteria to stay in a
safe distance from host cell cytotoxicity and still achieve
the release of nutrients. Thus, shedding of vesicles ﬁlled
with toxins, effector molecules and other factors may
interfere with the host cell and/or host immune responses,
thereby affecting the persistence of infection. Further
studies are needed to more fully characterize the interac-
tions between H. pylori vesicles and host cells, particularly
in regard to gastric tissue; however, valuable insights
have been provided by this study.
Experimental procedures
Bacterial strains and growth conditions
Bacterial strains used in this study: CCUG17875 (CCUG,
Gothenburg, Sweden); 17875/Leb (Ilver et al., 1998);
17875DbabA1::kanDbabA2::cam, here called 17875/sLex
(Mahdavi et al., 2002); P12 (Odenbreit et al., 1996);
P12DcagA (Backert et al., 2001) and P12DcagPAI (Backert
et al., 2005). Bacteria were grown on blood agar plates of
Brucella agar supplemented with 10% bovine blood (Svenska
Labfab, Sweden), 1% IsoVitox Enrichment (Dalynn Biologi-
cals), and an antibiotic mixture of amphotericin B (4 mg l
-1),
vancomycin (10 mg l
-1) and trimetoprim (5 mg l
-1). When
needed, the agar was supplemented with chloramphenicol
(20 mg l
-1) and/or kanamycin (25 mg l
-1). Bacteria were also
grown in Brucella broth supplemented with 10% calf serum
(Gibco), 1% IsoVitox Enrichment and the same antibiotic mix
described above. H. pylori were routinely grown at 37°C in a
microaerophilic environment of 5% O2, 10% CO2 and 85% N2.
Isolation of H. pylori vesicles
Isolation of H. pylori vesicles was performed according to Wai
et al. (2003) with the following modiﬁcations: H. pylori were
grown on blood agar plates for 2 days, harvested in 20 mM
Tris-HCl (pH 8.0), and centrifuged twice for 30 min at 8000 g
at 4°C. Alternatively, H. pylori were grown in broth culture to
early stationary phase and harvested by centrifugation for
30 min at 4000 g at 4°C. The supernatant was ﬁltered
through a 0.22 mm cellulose acetate ﬁlter and centrifugated
for 3 h at 150 000 g at 4°C. The pellet containing vesicles
was resuspended in 20 mM Tris-HCl (pH 8.0). To purify
vesicles according to density, vesicles were subjected to ﬂo-
tation in a continuous Histodenz gradient [20–60% Histodenz
(Sigma) in 250 mM sucrose/20 mM Tris-HCl (pH 8.0)] and
separated by equilibrium centrifugation for 16 h at 200 000 g
at 4°C (Lundmark and Carlsson, 2003). For separation of
vesicles according to size, crude vesicle preparations were
loaded on top of a 5–15% continuous Histodenz gradient and
centrifuged for 1.5 h at 150 000 g at 4°C. Vesicles were puri-
ﬁed from the Histodenz using a 4¥ dilution followed by ultra-
centrifugation for 90 min at 120 000 g at 4°C. The pellet
fraction was resuspended in 20 mM Tris-HCl (pH 8.0).
Average vesicle size was calculated by measuring their
diameter in electron micrographs representing 207 vesicles
(fraction 2); 146 (fraction 4); 188 (fraction 9).
Isolation of outer membranes
For the NMR analysis, total membrane samples were sepa-
rated into outer and inner membrane fractions using sucrose
density gradients and centrifugation as described by Horst-
man and Kuehn (2000). Brieﬂy, H. pylori cells were harvested
and washed in 20 mM Tris-HCl (pH 7.5) and centrifuged at
3000 g for 10 min. Frozen cells were lysed with X-press.
Unbroken cells were removed by centrifugation at 3000 g for
10 min. The supernatant was applied to a sucrose cushion
[2 ml 55% sucrose, 0.5 ml 5% sucrose in 20 mM Tris-HCl
(pH 7.5)/0.5 mM EDTA]. Membranes were removed from the
interface with a syringe needle (19 gauge) and diluted to
2.5 ml in 20 mM Tris-HCl (pH 7.5)/0.5 mM EDTA. Diluted
membranes were loaded on a stepwise sucrose gradient
(0.4 ml 60%, 0.9 ml 55%, 2.2 ml 50%, 2.2 ml 45%, 2.2 ml
40%, 1.3 ml 35% and 0.4 ml 30%) and centrifuged at
150 000 g for 18 h. Fractions were collected from the bottom
in the same volumes described for the composition of the
stepwise gradient.
For immunoblots in Fig. 5D, total membrane was sepa-
rated into outer and inner membrane fractions using deter-
gent for comparison of protein components in OM and
vesicles. Brieﬂy, total membranes were isolated as above and
incubated 30 min in 2% N-laurylsarcosyl at room temperature
(RT). OM proteins were collected by centrifugation for 30 min
at 50 000 g at 4°C.
Isolation of lipids
Lipids were isolated essentially as previously described
(Hamiltonet al.,1992)usingmethanol/chloroformextractions.
Lipids were solubilized in deuterated chloroform : methanol
(2:1). To avoid paramagnetic contamination, CsEDTA was
addedtoaﬁnalconcentrationof10 mMaccordingtoMeneses
and Glonek (1988).
NMR analysis
High-resolution NMR spectra were recorded on a DRX600
NMRspectrometer(Bruker,Fällanden,Switzerland)equipped
with a
1H,
13C,
31P cryo-probe with z-gradient. NMR spectra
were processed using TopSpin Software 2.0 (Bruker). The
amount of lipid sample ranged from 0.5 to 10 mg, with corre-
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vidual phospholipid respectively. Two-dimensional
31P,
1H
correlation spectra were used to unambiguously assign phos-
pholipids based on their
31P and
1H chemical shifts, and
31P,
1H
J couplings. Using one-dimensional projections of the 2D
spectra, the relative amount of each phospholipid was esti-
matedbyintegrationofthepeakarea(Petzoldet al.,2009).To
calculate the concentration of cholesterol, 2D
13C,
1H correla-
tions were recorded according to (Sattler et al., 1999). For this
purpose, integrals of well-resolved C-H groups of cholesterol
and PG were compared.
SDS-PAGE and immunoblot analysis
Protein samples were separated on 4–12% Bis-Tris gel (Invit-
rogen) or 10% or 15% gels and stained with Commassie
Page Blue (Fermentas). BCA Protein Assay Kit (Pierce) or
Quibit ﬂuorometeter (Invitrogen) was used for measurements
of protein concentration. Protein extracts contain 2% SDS to
eliminate any interference from lipids.
Immunoblots were performed essentially as previously
described by Bäckström et al. (2004). Primary antibodies
included: anti-BabA (AK277) (Odenbreit et al., 2002b); anti-
SabA (AK278) (Odenbreit et al., 2002b); anti-CagA (Austral
Biologicals); anti-VacA (AK204) (Fischer et al., 2001); anti-
AlpB (AK262) (Odenbreit et al., 2002a); anti-OipA (AK282)
(Kudo et al., 2004); anti-ComB10 (AK252) (Hofreuter et al.,
2001); anti-CagT; anti-CagX; anti-CagY; anti-CagM; anti-
CagN; anti-VirD4. Secondary antibody: anti-rabbit horser-
adish peroxidase (DakoCytomation). Membranes were
developed using Supersignal West Pico Chemiluminescence
Substrate (Pierce) and signals were recorded using X-ray ﬁlm
or scanning using Kodak Molecular Imaging Software 4.0.3.
Quantiﬁcation of vesicle proteins
Quantiﬁcation of speciﬁc proteins in OM and vesicle samples
was performed with immunoblot analysis. Series of 1, 2 and
4 mg protein from each sample, respectively, were loaded on
SDS-PAGE gels and stained to verify the correct amount of
loaded samples. Next, samples were separated by SDS-
PAGE and blotted on to PVDF membranes and probed with
antibodies. The densities of signals in the serial dilutions for
each sample were measured with the Image J program
(http://rsbweb.nih.gov/ij/). Linear regression was applied to
data from three-four experiment sets of immunoblots to
establish the density for each protein prior to calculation of
the relative ratio of OM and vesicles.
In-gel protein digestion
In-gel protein digestion with trypsin was performed as
described by Shevchenko et al. (1996) with some minor
modiﬁcations. Brieﬂy, gel pieces were destained by washing
three times in 25 mM NH4HCO3/50% CH3CN and one time
in 25 mM NH4HCO3/50% CH3OH. Gel pieces were dried in
a vacuum centrifuge and incubated with digestion buffer
(50 mM NH4HCO3,1 0 n g ml
-1 trypsin) at 37°C overnight.
Peptides were extracted in 50% CH3CN/1% CH3COOH and
the supernatant evaporated in a vacuum centrifuge. Prior to
MS analysis, the peptides were reconstituted in 0.2%
HCOOH.
Nanoﬂow LC FT-ICR MS/MS and database searches
Sample injections were made with an HTC-PAL autosampler
(CTC Analytics AG, Zwingen, Switzerland) connected to an
Agilent 1100 binary pump (Agilent Technologies, Palo Alto,
CA, USA). Peptides were trapped on a pre-column and sepa-
rated on a reversed phase column. The nanoﬂow LC-MS/MS
was performed on a hybrid linear ion trap-FT-ICR mass spec-
trometer equipped with a 7T ICR magnet (LTQ-FT, Thermo
Electron,Bremen,Germany).Thespectrometerwasoperated
in data-dependent mode that automatically switched to
MS/MS mode. MS spectra were acquired in the FT-ICR, while
MS/MS spectra were acquired in the LTQ trap. For each scan
of FT-ICR, the three most intense ions, doubly or triply
charged, were sequentially fragmented in the linear trap by
collision-induced dissociation. All the tandem mass spectra
obtained were submitted to MASCOT (Matrix Science,
London) for comparisons against all species in the NCBI
database, MS I; NCBInr 080130 (5 878 816 sequences), MS
II;NCBInr060802(3 841 279sequences).Thesearchparam-
eters included MS accuracy of 5 p.p.m., MS/MS accuracy of
0.5 Da, one missed cleavage by trypsin was allowed, ﬁxed
propionamide modiﬁcation of cysteine, and variable modiﬁca-
tion of oxidized methionine. For protein identiﬁcation, the
minimum criteria were, one tryptic peptide match at or above
the 99% level of conﬁdence (MOWSE score > 45) and an
additional peptide match at the 95% level (MOWSE
score > 30). Strain CCUG17875 used in the MS analysis is
not genome sequenced. Therefore, when multiple proteins
matched the same set of peptides, we report Gene bank
accession number from H. pylori strains in the following order;
26695, J99, HPAG1 and other H. pylori strains. Strain 26695
was chosen as a reference strain for gene numbers that are
presentedinTable S1.Forhomologousproteins,withdifferent
scores, a sequence distance over 90% (MegAlign, DNAstar),
was required. The Gene bank accession number with the
highest MOWSE score is presented.The biological function of
identiﬁed proteins was assigned by COG classiﬁcation,
Clusters of Orthologous Groups of proteins (http://www.
ncbi.nlm.nih.gov/COG). H. pylori OM proteins, deﬁned byAlm
et al. (Alm et al., 2000), were sorted into a separate class.
Sequence coverage was calculated in per cent by dividing the
number of amino acids in matched peptides with the total
numberofaminoacidsintheidentiﬁedprotein.Twenty-sixhits
against human and cow proteins were deleted.
Receptor affinity replacement assay
Scatchard analysis was performed as previously described
(Aspholm et al., 2006b). Brieﬂy, solutions with 0.2 ng
125I-
labelled Leb receptor glyco-conjugate and unlabelled conju-
gate (HSA-Leb) (IsosepAB, Tullinge, Sweden) were added in
a dilution series from 0 to 4 ng to eight samples of whole cells
and vesicles respectively. A Leb-non-binding strain was
added to the samples as a carrier to facilitate pelleting of the
vesicles. The pellet and supernatant of the vesicles were
separated after centrifugation for 1 h at 42 000 g at 4°C, while
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16 000 g. Affinity (Ka) corresponds to the slope of the respec-
tive curve.
Electron microscopy analyses
Samples of whole-cell H. pylori and isolated vesicle samples
were applied to formvar-coated copper grids, negatively
stained with 1% sodium silicotungstate, and analysed with a
JEOL 1230 transmission electron microscope. Immunogold
analysis was performed as described in Bäckström et al.
(2004) using biotinylated-Leb or biotinylated-sLex, detected
with 10 nm gold-anti-biotin (GAB10: British Biocell Interna-
tional, Cardiff, UK). Anti-CagA antibodies were detected with
10 nm gold-anti-rabbit particles (GAR10: British Biocell
International). Double-staining was performed using anti-
BabA antibodies and 10 nm gold particles (GAR10) in com-
bination with biotinylated-sLex and 5 nm gold particles
(GAB5). Calculations of Leb-binding vesicles were based on
a series of electron micrographs representing in total 524
vesicles (fraction 2), 351 (fraction 4) and 183 (fraction 9).
Adherence to gastric tissue sections
Human gastric tissues were deparaffinized and blocked in
blocking buffer [1¥ PBS (5 mM KH2PO4/20 mM K2HPO4/
85 mM NaCl)/0.05% Tween-20/1% BSA] at RT for 1 h.H .
pylori vesicles puriﬁed by a Histodenz gradient were added to
the tissue sections and incubated for 2 h. Alternatively,
vesicles were pre-incubated with Leb or sLex receptor con-
jugate for 2 h prior to addition to tissue sections. Tissue
sections were washed in washing buffer (1¥ PBS/0.05%
Tween-20), blocked with blocking buffer for 20 min, then incu-
bated with biotinylated anti-H. pylori antibody (Abcam, Cam-
bridge, UK) overnight at 4°C and thereafter for 1 h at RT.
Tissue sections were subsequently washed and incubated
with streptavidin-Cy3 (Amersham Bioscience) for 1 h. Cy3-
ﬂuorescence on tissue sections was analysed using a Zeiss
AxioImager Z1 microscope, apotome andAxiovision software
v4.5. Alternatively, biotinylated anti-H. pylori antibody was
detected with streptavidin-ABComplex (DAKO A/S) for 1 h
and DAB+ (Carpinteria, CA, USA) followed by counterstain-
ing with Mayers haematoxylin.
Trypsin digestion of vesicles
Puriﬁed P12 vesicles were subjected to trypsin digestion
(10%) for 1 h on ice either in the presence or absence of 1%
NP40 (Thermo Scientiﬁc, Waltham, USA). Samples were
subsequently resuspended in SDS-PAGE sample buffer,
separated by SDS-PAGE, and proteins detected in immuno-
blots using anti-CagA, anti-VacA and anti-BabA antibodies.
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